Role of serum interleukin-18 as a prognostic factor in patients with hepatocellular carcinoma

doi:10.3748/wjg.v13.i32.4345

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 32

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3174)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

299

HTML

2655

Figures (1-1)

106

Tables (1-4)

114

Sum=3174

Aug 28, 2007 (publication date) through Apr 15, 2024

Times Cited of This Article

Times Cited (45)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Aug 28, 2007; 13(32): 4345-4349
Published online Aug 28, 2007. doi: 10.3748/wjg.v13.i32.4345

Open in New Tab Full Size Figure Download Figure

Figure 1 Overall survival of HCC patients with low serum IL-18 level (< 10⁵ pg/mL) or high IL-18 level (≥ 10⁵ pg/mL). A: All patients; B: Patients who were treated with surgery or TOCE; C: Untreated patients.

Citation: Tangkijvanich P, Thong-ngam D, Mahachai V, Theamboonlers A, Poovorawan Y. Role of serum interleukin-18 as a prognostic factor in patients with hepatocellular carcinoma. World J Gastroenterol 2007; 13(32): 4345-4349
URL: https://www.wjgnet.com/1007-9327/full/v13/i32/4345.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i32.4345